Rhumbline Advisers Has $186.91 Million Stock Position in CME Group Inc. (NASDAQ:CME)

Rhumbline Advisers increased its stake in shares of CME Group Inc. (NASDAQ:CME - Free Report) by 3.4% during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The firm owned 704,549 shares of the financial services provider's stock after acquiring an additional 22,917 shares during the quarter. Rhumbline Advisers owned about 0.20% of CME Group worth $186,910,000 at the end of the most recent reporting period.

Other institutional investors and hedge funds also recently made changes to their positions in the company. New Age Alpha Advisors LLC increased its holdings in CME Group by 50.0% in the 4th quarter. New Age Alpha Advisors LLC now owns 129 shares of the financial services provider's stock valued at $30,000 after buying an additional 43 shares during the period. Financial Life Planners bought a new stake in CME Group in the fourth quarter valued at about $32,000. Knuff & Co LLC bought a new stake in CME Group in the fourth quarter valued at about $33,000. Banque Transatlantique SA acquired a new position in CME Group in the fourth quarter worth about $35,000. Finally, Whipplewood Advisors LLC bought a new position in CME Group during the fourth quarter worth about $37,000. Institutional investors own 87.75% of the company's stock.

CME Group Price Performance

Shares of NASDAQ CME traded down $8.40 during trading on Tuesday, reaching $282.31. The company had a trading volume of 2,745,669 shares, compared to its average volume of 2,188,928. CME Group Inc. has a 52 week low of $190.70 and a 52 week high of $290.79. The business's 50 day moving average price is $270.54 and its 200-day moving average price is $251.90. The stock has a market cap of $101.73 billion, a PE ratio of 29.19, a PEG ratio of 6.76 and a beta of 0.45. The company has a debt-to-equity ratio of 0.10, a quick ratio of 1.02 and a current ratio of 1.01.

CME Group (NASDAQ:CME - Get Free Report) last posted its quarterly earnings data on Wednesday, April 23rd. The financial services provider reported $2.80 earnings per share for the quarter, topping the consensus estimate of $2.61 by $0.19. CME Group had a net margin of 57.52% and a return on equity of 13.62%. The firm had revenue of $1.64 billion during the quarter, compared to analysts' expectations of $1.56 billion. During the same quarter in the previous year, the company posted $2.50 EPS. CME Group's revenue was up 10.4% on a year-over-year basis. Analysts expect that CME Group Inc. will post 10.49 earnings per share for the current year.

CME Group Announces Dividend

The company also recently announced a quarterly dividend, which will be paid on Wednesday, June 25th. Stockholders of record on Monday, June 9th will be given a dividend of $1.25 per share. The ex-dividend date of this dividend is Monday, June 9th. This represents a $5.00 dividend on an annualized basis and a dividend yield of 1.77%. CME Group's payout ratio is currently 50.30%.

Analyst Upgrades and Downgrades

CME has been the topic of several analyst reports. Piper Sandler upped their price objective on CME Group from $275.00 to $283.00 and gave the company an "overweight" rating in a research note on Tuesday, April 8th. Keefe, Bruyette & Woods increased their price objective on CME Group from $265.00 to $273.00 and gave the stock a "market perform" rating in a research note on Thursday, April 24th. Royal Bank of Canada reissued a "sector perform" rating and set a $269.00 price objective on shares of CME Group in a report on Thursday, April 3rd. Erste Group Bank lowered shares of CME Group from a "strong-buy" rating to a "hold" rating in a report on Saturday, May 24th. Finally, Bank of America increased their target price on shares of CME Group from $200.00 to $219.00 and gave the stock an "underperform" rating in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, eight have issued a hold rating and five have given a buy rating to the company. According to data from MarketBeat, CME Group currently has an average rating of "Hold" and an average price target of $256.80.

Insider Transactions at CME Group

In other news, Director Howard J. Siegel sold 10,000 shares of the firm's stock in a transaction on Thursday, March 13th. The stock was sold at an average price of $260.00, for a total value of $2,600,000.00. Following the transaction, the director now directly owns 21,873 shares in the company, valued at $5,686,980. This trade represents a 31.37% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Daniel G. Kaye sold 500 shares of CME Group stock in a transaction on Thursday, May 22nd. The stock was sold at an average price of $282.42, for a total value of $141,210.00. Following the sale, the director now directly owns 3,668 shares of the company's stock, valued at approximately $1,035,916.56. This trade represents a 12.00% decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders sold a total of 22,900 shares of company stock worth $6,147,935 over the last 90 days. 0.30% of the stock is owned by insiders.

About CME Group

CME Group Inc, together with its subsidiaries, operates contract markets for the trading of futures and options on futures contracts worldwide. It offers futures and options products based on interest rates, equity indexes, foreign exchange, agricultural commodities, energy, and metals, as well as fixed income and foreign currency trading services.